These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
289 related articles for article (PubMed ID: 31187152)
1. Highs and lows of cannabinoid-dopamine interactions: effects of genetic variability and pharmacological modulation of catechol-O-methyl transferase on the acute response to delta-9-tetrahydrocannabinol in humans. Ranganathan M; De Aquino JP; Cortes-Briones JA; Radhakrishnan R; Pittman B; Bhakta S; D'Souza DC Psychopharmacology (Berl); 2019 Nov; 236(11):3209-3219. PubMed ID: 31187152 [TBL] [Abstract][Full Text] [Related]
2. COMT Val(158)Met genotype determines the direction of cognitive effects produced by catechol-O-methyltransferase inhibition. Farrell SM; Tunbridge EM; Braeutigam S; Harrison PJ Biol Psychiatry; 2012 Mar; 71(6):538-44. PubMed ID: 22364739 [TBL] [Abstract][Full Text] [Related]
3. Improvement of prepulse inhibition and executive function by the COMT inhibitor tolcapone depends on COMT Val158Met polymorphism. Giakoumaki SG; Roussos P; Bitsios P Neuropsychopharmacology; 2008 Dec; 33(13):3058-68. PubMed ID: 18536698 [TBL] [Abstract][Full Text] [Related]
4. Genetic moderation of the effects of cannabis: catechol-O-methyltransferase (COMT) affects the impact of Δ9-tetrahydrocannabinol (THC) on working memory performance but not on the occurrence of psychotic experiences. Tunbridge EM; Dunn G; Murray RM; Evans N; Lister R; Stumpenhorst K; Harrison PJ; Morrison PD; Freeman D J Psychopharmacol; 2015 Nov; 29(11):1146-51. PubMed ID: 26464454 [TBL] [Abstract][Full Text] [Related]
5. Acute effects of Δ9-tetrahydrocannabinol (THC) on resting state connectivity networks and impact of COMT genotype: A multi-site pharmacological fMRI study. Pelgrim TAD; Ramaekers JG; Wall MB; Freeman TP; Bossong MG Drug Alcohol Depend; 2023 Oct; 251():110925. PubMed ID: 37598453 [TBL] [Abstract][Full Text] [Related]
6. Effects of pharmacological and genetic regulation of COMT activity in alcohol use disorder: a randomized, placebo-controlled trial of tolcapone. Schacht JP; Yeongbin Im ; Hoffman M; Voronin KE; Book SW; Anton RF Neuropsychopharmacology; 2022 Oct; 47(11):1953-1960. PubMed ID: 35523943 [TBL] [Abstract][Full Text] [Related]
7. Acute effects of ∆9-tetrahydrocannabinol (THC) on resting state brain function and their modulation by COMT genotype. Bossong MG; van Hell HH; Schubart CD; van Saane W; Iseger TA; Jager G; van Osch MJP; Jansma JM; Kahn RS; Boks MP; Ramsey NF Eur Neuropsychopharmacol; 2019 Jun; 29(6):766-776. PubMed ID: 30975584 [TBL] [Abstract][Full Text] [Related]
8. Effects of tolcapone on working memory and brain activity in abstinent smokers: a proof-of-concept study. Ashare RL; Wileyto EP; Ruparel K; Goelz PM; Hopson RD; Valdez JN; Gur RC; Loughead J; Lerman C Drug Alcohol Depend; 2013 Dec; 133(3):852-6. PubMed ID: 24095246 [TBL] [Abstract][Full Text] [Related]
9. An experimental study of catechol-o-methyltransferase Val158Met moderation of delta-9-tetrahydrocannabinol-induced effects on psychosis and cognition. Henquet C; Rosa A; Krabbendam L; Papiol S; Fananás L; Drukker M; Ramaekers JG; van Os J Neuropsychopharmacology; 2006 Dec; 31(12):2748-57. PubMed ID: 16936704 [TBL] [Abstract][Full Text] [Related]
10. Enhancing dopamine tone modulates global and local cortical perfusion as a function of COMT val158met genotype. Furman DJ; Pappas I; White RL; Kayser AS; D'Esposito M Neuroimage; 2021 Nov; 242():118472. PubMed ID: 34390874 [TBL] [Abstract][Full Text] [Related]
11. Brain catechol-O-methyltransferase (COMT) inhibition by tolcapone counteracts recognition memory deficits in normal and chronic phencyclidine-treated rats and in COMT-Val transgenic mice. Detrait ER; Carr GV; Weinberger DR; Lamberty Y Behav Pharmacol; 2016 Aug; 27(5):415-21. PubMed ID: 26919286 [TBL] [Abstract][Full Text] [Related]
12. Effects of COMT genotype and tolcapone on lapses of sustained attention after sleep deprivation in healthy young men. Valomon A; Holst SC; Borrello A; Weigend S; Müller T; Berger W; Sommerauer M; Baumann CR; Landolt HP Neuropsychopharmacology; 2018 Jun; 43(7):1599-1607. PubMed ID: 29472644 [TBL] [Abstract][Full Text] [Related]
13. Catechol-O-methyltransferase activity does not influence emotional processing in men. Martens MA; Dalton N; Scaife J; Harmer CJ; Harrison PJ; Tunbridge EM J Psychopharmacol; 2022 Jun; 36(6):768-775. PubMed ID: 35443830 [TBL] [Abstract][Full Text] [Related]
14. Effect of tolcapone on brain activity during a variable attentional control task: a double-blind, placebo-controlled, counter-balanced trial in healthy volunteers. Magalona SC; Rasetti R; Chen J; Chen Q; Gold I; Decot H; Callicott JH; Berman KF; Apud JA; Weinberger DR; Mattay VS CNS Drugs; 2013 Aug; 27(8):663-73. PubMed ID: 23794107 [TBL] [Abstract][Full Text] [Related]
15. Effects of tolcapone and bromocriptine on cognitive stability and flexibility. Cameron IGM; Wallace DL; Al-Zughoul A; Kayser AS; D'Esposito M Psychopharmacology (Berl); 2018 Apr; 235(4):1295-1305. PubMed ID: 29427081 [TBL] [Abstract][Full Text] [Related]
16. Dopaminergic modulation of regional cerebral blood flow: An arterial spin labelling study of genetic and pharmacological manipulation of COMT activity. Martens M; McConnell FK; Filippini N; Mackay CE; Harrison PJ; Tunbridge EM Neuroimage; 2021 Jul; 234():117999. PubMed ID: 33789133 [TBL] [Abstract][Full Text] [Related]
17. Dopamine, locus of control, and the exploration-exploitation tradeoff. Kayser AS; Mitchell JM; Weinstein D; Frank MJ Neuropsychopharmacology; 2015 Jan; 40(2):454-62. PubMed ID: 25074639 [TBL] [Abstract][Full Text] [Related]
18. Chronic adolescent exposure to delta-9-tetrahydrocannabinol in COMT mutant mice: impact on indices of dopaminergic, endocannabinoid and GABAergic pathways. Behan AT; Hryniewiecka M; O'Tuathaigh CM; Kinsella A; Cannon M; Karayiorgou M; Gogos JA; Waddington JL; Cotter DR Neuropsychopharmacology; 2012 Jun; 37(7):1773-83. PubMed ID: 22434221 [TBL] [Abstract][Full Text] [Related]
19. Genetic vs. pharmacological inactivation of COMT influences cannabinoid-induced expression of schizophrenia-related phenotypes. O'Tuathaigh CM; Clarke G; Walsh J; Desbonnet L; Petit E; O'Leary C; Tighe O; Clarke N; Karayiorgou M; Gogos JA; Dinan TG; Cryan JF; Waddington JL Int J Neuropsychopharmacol; 2012 Oct; 15(9):1331-42. PubMed ID: 22074909 [TBL] [Abstract][Full Text] [Related]
20. Catechol-O-methyltransferase val108/158met genotype predicts working memory response to antipsychotic medications. Weickert TW; Goldberg TE; Mishara A; Apud JA; Kolachana BS; Egan MF; Weinberger DR Biol Psychiatry; 2004 Nov; 56(9):677-82. PubMed ID: 15522252 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]